Globeflex Capital’s Pfizer PFE Stock Holding History

Globeflex Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-186,365	Closed	-$6.18M	–	500
2023 Q3	$6.18M	Hold	186,365	–	–	0.72%	32
2023 Q2	$6.84M	Hold	186,365	–	–	0.76%	28
2023 Q1	$7.6M	Hold	186,365	–	–	0.93%	21
2022 Q4	$9.55M	Buy	186,365 +97,100	+109%	+$4.66M	1.21%	13
2022 Q3	$3.91M	Buy	89,265 +86,721	+3,409%	+$4.21M	0.67%	26
2022 Q2	$133K	Hold	2,544	–	–	0.03%	354
2022 Q1	$132K	Buy	+2,544	New	+$132K	0.03%	371
2021 Q4	–	Sell	-85	Closed	-$4K	–	494
2021 Q3	$4K	Buy	85 +49	+136%	+$2.17K	﹤0.01%	422
2021 Q2	$1K	Hold	36	–	–	﹤0.01%	452
2021 Q1	$1K	Hold	36	–	–	﹤0.01%	449
2020 Q4	$1K	Sell	36 -2	-5%	-$73	﹤0.01%	470
2020 Q3	$1K	Hold	38	–	–	﹤0.01%	467
2020 Q2	$1K	Hold	38	–	–	﹤0.01%	489
2020 Q1	$1K	Hold	38	–	–	﹤0.01%	504
2019 Q4	$1K	Hold	38	–	–	﹤0.01%	519
2019 Q3	$1K	Hold	38	–	–	﹤0.01%	504
2019 Q2	$2K	Buy	+38	New	+$1.51K	﹤0.01%	476

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Globeflex Capital's PFE Position: Q4 2023 in Review

Globeflex Capital sold out of Pfizer (PFE) in Q4 2023, closing a stake of 186,365 shares — an estimated $6.18M sold.

Globeflex Capital first reported a position in PFE in Q2 2019 and held it in 17 quarters. The position peaked at $9.55M in Q4 2022. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

Globeflex Capital reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
Globeflex Capital sold 186,365 Pfizer shares in Q4 2023, an estimated $6.18M.
Globeflex Capital first reported a position in Pfizer in Q2 2019 and held it in 17 quarters.
Globeflex Capital's Pfizer position peaked at $9.55M in Q4 2022.
2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on Globeflex Capital's 13F filing for Q4 2023, filed 13 Feb 2024.